Lancet 1984 November 10; 2(8411): 1098-1099
Showing items related by title, author, creator and subject.
Early Termination of Drug Trials: What Are the Ramifications for Drug Companies and Drug Safety Monitoring Boards? Jensen, Gorm Boje; Hampton, John (2007-02-17)
A Bill to Amend the Federal Food, Drug and Cosmetic Act to Provide for a Federal Drug Compendium Which Provides Reliable, Complete, and Readily Accessible Prescribing Information; to Assure Safety and Efficacy of Drugs Through Certification Of Certain Drugs Other Than Insulin and Antibiotics; to Require Certain Information in Drug Labeling; and to Improve the Administration and Enforcement of the Act as It Relates to Drugs Unknown author (United States. Congress. Senate, 1979)